investment

Devoted Health raises $1.1B, sending valuation soaring past $12B

Though the Medicare Advantage-focused insurance technology startup is smaller than rivals like Clover Health in terms of membership and revenues, this latest financing round places it ahead of, or at least on par with, several larger competitors with regard to total funds raised.

Vera Whole Health grabs Morgan Health’s interest — and a $50M investment

Morgan Health, JPMorgan Chase’s business unit, has made its first-ever investment in a company that provides a coordinated primary care model. Vera Whole Health operates a network of primary clinics across 10 states, supported by a technology platform.

Bon Secours Mercy Health invests in Trilliant Health as part of larger push into analytics

The health system has invested an undisclosed amount in Trilliant Health, which provides a predictive analytics platform giving users insights into market dynamics. Bon Secours Mercy Health is also a founding member of another healthcare data company: Truveta.

When biotech meets reality TV – Starton Therapeutics faces the Unicorn Hunters

Starton Therapeutics is bypassing the traditional venture capital route to raise money for its transdermal delivery technology that delivers medicine through the skin. pharmaphorum hears why the company decided to appear on a new reality investment show. A big clock times a 60 second countdown as biotech CEO Pedro Lichtinger delivers an elevator pitch to …

When biotech meets reality TV – Starton Therapeutics faces the Unicorn Hunters Read More »

Kaiser Permanente, Mayo Clinic invest $100M in hospital-at-home company

The health systems are sinking a combined $100 million into Medically Home Group, which enables clinicians to provide hospital-level care in patients’ homes. The funds are intended to scale the company’s operations and expand access to its care delivery model.

Investment in healthcare is soaring, but entrepreneurs must be wary of over-capitalizing  

The Covid-19 pandemic pushed the already impressive growth in healthcare investing to new heights, with valuations on the rise and companies gaining access to vast sums of money. But speakers at a MedCity INVEST panel warned that raising more capital than needed is not always a good thing.

The Alderley Park Discovery Podcast: The journey to accessing science funding and investment

Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors. In this instalment, Dominic Tyer is joined by Kinomica CEO Jane Theaker, BioCity investment director Claire Brown, Redx Pharma CEO Lisa Anson and Dr Kath Mackay, managing director at Bruntwood …

The Alderley Park Discovery Podcast: The journey to accessing science funding and investment Read More »

UK chancellor Sunak urged to boost pharma and biotech in budget

UK chancellor Rishi Sunak has been urged to recognise the leading role that pharma companies are playing in the economy in this week’s budget. Sunak is due to make his closely-watched budget speech tomorrow (Wednesday) in the House of Commons, starting from about 12.30. The Conservative Party has strong ties with pharma and life sciences …

UK chancellor Sunak urged to boost pharma and biotech in budget Read More »

Disgraced biotech investor Woodford plans revival as UK biotech booms

Disgraced investor Neil Woodford plans to start a new biotech investment firm as he seeks to capitalise on a booming UK life sciences industry and rebuild his reputation following the collapse of his previous fund. According to press reports, Woodford will be chief investment officer of Woodford Capital Management. The news was first reported by …

Disgraced biotech investor Woodford plans revival as UK biotech booms Read More »

UK biotech investment at record levels amid COVID-19

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in …

UK biotech investment at record levels amid COVID-19 Read More »

Consumer awareness, needs generating shifts in precision medicine landscape  

Healthcare consumers are increasingly aware of specific therapies in development or on the market that can help treat the diseases they or their loved ones may be suffering from — and this growing awareness is changing the precision medicine arena.

Olive Tree Ventures closes $170m dedicated digital health fund

Israel’s specialist venture capital firm, Olive Tree Ventures (OTV) has closed a fund worth $170 million, with plans to expand its portfolio of digital health firms. OTV is the only VC in Israel whose main focus is digital health, specialising in supporting portfolio companies reaching maturity. This includes help with regulatory hurdles and marketing of …

Olive Tree Ventures closes $170m dedicated digital health fund Read More »

COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts

Despite the UK’s world class research output and the many start-ups successfully spinning out from its academic institutions, in recent years UK biotech companies have struggled to access the capital they need to scale up and make their mark on the industry. The COVID-19 pandemic has brought about a radical transformation, with investors now eager …

COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts Read More »

Cerner and LRVHealth invest $6m in digital health firm Xealth

Health technology firms Cerner and LRVHealth have invested $6 million in Xealth to scale up its business offering digital health tools to patients and clinicians. The companies said the new relationship aims to give patients control over their own digital data so they can be more engaged in their treatment plans. Cerner and LRVHealth join …

Cerner and LRVHealth invest $6m in digital health firm Xealth Read More »

Five VCs share how the pandemic has changed investing

Months into the Covid-19 pandemic, the pace of new investments for startups has picked back up. Five VCs shared what’s changed and how they’re working in the midst of the crisis.